Discussion of ISCP 2017 - Treatment of Heart Failure in 2017 - Joint Session ISCP and Cardio Vascular Clinical Trialist forum (I)

↳ This is a section part of Moment: ISCP 2017 - Treatment of Heart Failure in 2017 - Joint Session ISCP and Cardio Vascular Clinical Trialist forum (I)

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$19.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Discussion of Treatment of Heart Failure at ISCP 2017.

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$19.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Cardiologists, interventional Cardiologists
  • Interventional Fellows
  • Interventional Radiologists
  • Vascular Surgeons
  • Emergency Physicians

Learning Objectives

Other Components in this Moment

Overview
Electrolytes and Renal Function in Heart Failure - Celso Amodeo
Raas Dual Inhibition and Beyond in Heart Failure Treatment - Felipe Martínez
The Effect of Coenzyme Qlo on Morbidity and Mortality in Chronic Heart Failure - Krzysztof Filipiak
Antidiabetic Drugs in Management of Heart Failure - The New Revolution? - Xavier Garcia-Moll
Guidelines Update - José Luis López Sendón
Mineralcorticoid Receptor Antagonist: Even More Evidence - Faiez Zannad
Discussion of ISCP 2017 - Treatment of Heart Failure in 2017 - Joint Session ISCP and Cardio Vascular Clinical Trialist forum (I)
Loading Simple Education